XML 41 R29.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION: (Tables)

6 Months Ended

Sep. 30, 2020

Schedule of stock-based compensation activity, by award type

The Company's stock-based compensation activity for the six months ended September 30, 2020, by award type, was (dollars in millions):


	For the six months ended
	September 30,
	2020		2019
Stock options	$	1.4	$	1.8

Restricted stock units	24.8		25.4
Arbor acquisition consideration holdback	—		2.6
DPM acquisition consideration holdback	4.0		2.1
PDP assumed performance plan	9.2		9.5
Acuity performance plan	0.7		—
Other non-employee stock-based compensation	0.6		0.6
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	40.7		42.0
Less expense related to liability-based equity awards	(12.8)		(10.7)

Total non-cash stock-based compensation included in the condensed consolidated statements of equity	$	27.9	$	31.3

Schedule of effect of stock-based compensation expense on income, by financial statement line item

The effect of stock-based compensation expense on income, by financial statement line item, was (dollars in millions):


	For the six months ended
	September 30,
	2020		2019
Cost of revenue	$	1.7	$	1.8
Research and development	13.6		10.0
Sales and marketing	16.4		18.7
General and administrative	9.0		11.5
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	$	40.7	$	42.0

Schedule of share based compensation arrangement by share based payment award, future expense

The following table provides the expected future expense for all of the Company's outstanding equity awards at September 30, 2020, by award type. The amount for 2021 represents the remaining six months ending March 31, 2021. All other periods represent fiscal years ending March 31 (dollars in millions).


	For the years ending March 31,
	2021		2022		2023		2024		2025		Total
Stock options	$	0.8	$	1.1	$	0.3	$	—	$	—	$	2.2
Restricted stock units	32.5		56.6		43.8		22.9		3.1		158.9
DPM acquisition consideration holdback	4.1		8.1		2.0		—		—		14.2
PDP assumed performance plan	9.2		9.2		—		—		—		18.4
Acuity performance plan	1.5		1.9		0.9		0.2		—		4.5
	$	48.1	$	76.9	$	47.0	$	23.1	$	3.1	$	198.2

Schedule of option activity

Stock option activity for the six months ended September 30, 2020 was:


				Weighted-average
		Weighted-average		remaining	Aggregate
	Number of	exercise price		contractual term	Intrinsic value
	shares	per share		(in years)	(in thousands)
Outstanding at March 31, 2020	1,350,658	$	14.43

Exercised	(154,165)	$	10.74		$	6,025
Forfeited or canceled	(5,024)	$	1.72
Outstanding at September 30, 2020	1,191,469	$	14.96	2.9	$	43,855
Exercisable at September 30, 2020	1,144,331	$	15.50	2.7	$	41,506

Summary of stock options outstanding and exercisable

A summary of stock options outstanding and exercisable as of September 30, 2020 was:


					Options outstanding				Options exercisable
Range of						Weighted-average	Weighted-average			Weighted-average
exercise price					Options	remaining	exercise price		Options	exercise price
per share					outstanding	contractual life	per share		exercisable	per share
$	0.61	—	$	9.99	148,147	5.1 years	$	1.50	101,009	$	1.30
$	10.00	—	$	19.99	691,732	2.0 years	$	14.62	691,732	$	14.62
$	20.00	—	$	24.99	351,590	3.6 years	$	21.31	351,590	$	21.31

					1,191,469	2.9 years	$	14.96	1,144,331	$	15.50

Schedule of time-vesting restricted stock unit activity

RSU activity for the six months ended September 30, 2020 was:


		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2020	3,351,638	$	40.68	2.51
Granted	1,824,342	$	39.85
Vested	(629,538)	$	41.56
Forfeited or canceled	(294,861)	$	41.43
Outstanding at September 30, 2020	4,251,581	$	40.14	2.70

Schedule of non-vested performance-based restricted stock units activity

PSU activity for the six months ended September 30, 2020 was:


		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2020	545,446	$	51.01	2.24
Granted	246,524	$	43.40
Additional earned performance shares	38,063	$	55.48
Vested	(121,587)	$	48.88
Forfeited or canceled	(32,647)	$	34.22
Outstanding at September 30, 2020	675,799	$	49.68	2.03